WeightRx Tirzepatide Review: Cost, an Annual Rate Disguised as Monthly & Honest Verdict (2026)

WeightRx: both of its product pages linked from the homepage return 404, so the actual plan terms cannot be read before starting the intake. Every fact here comes from the company's own published program.

A $83/month headline that's actually a locked year

Worth flagging directly is the advertised "$83/month" figure is presented alongside the fine print "($997/year)" — meaning it is a twelve-month prepaid rate, not a true monthly price. No separate month-to-month rate is published, and the terms state the rate locks for the full term. This review also that both linked product pages return 404, so the dose strength and plan terms behind that price can't be verified before you commit.

What WeightRx is

WeightRx is a telehealth provider, publishing compounded semaglutide at $250/month and compounded tirzepatide at the $83/month (prepaid annual) rate, with an online intake reviewed by a licensed clinician. The named operator is Twist G Marketing, LLC — a marketing entity name, not a clinical one.

What WeightRx costs

The product pages needed to see the actual dose strength and terms both 404. The headline $83/month tirzepatide price is really $997 paid upfront for a locked 12-month term, with six- and twelve-month plans non-refundable, and eligible refunds elsewhere carrying a 5% processing fee.

The brand-vs-compounded question

WeightRx dispenses compounded semaglutide and tirzepatide. Compounded tirzepatide is pharmacy-made, not itself an FDA-approved finished drug, and was not the specific product studied in the pivotal trials. See our guide to whether compounded tirzepatide is still legal in 2026 for the regulatory picture.

How the care model holds up

WeightRx's real strength is the low headline price does put tirzepatide in front of shoppers who might not otherwise click through. But the trade-offs are serious: this review that both product pages 404, meaning the plan terms can't be read before intake; the $83/month figure is really a $997 annual prepay with no dose strength disclosed anywhere, non-refundable 6- and 12-month plans with a 5% fee on eligible refunds, a marketing entity rather than a clinical one named as operator, and binding arbitration with a class-action waiver in the terms. As with any GLP-1 program, and especially one whose true price and dose aren't verifiable before you commit, read the actual terms directly rather than relying on the headline figure; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

WeightRx's headline $83/month price is genuinely eye-catching, but this review that its product pages 404 and, that figure is really a locked $997 annual prepay with no disclosed dose strength — a cheap headline price is often a signal to look closer, not a reason to trust it. For a provider with fully transparent, verifiable pricing, compare it against Vitara RX or VyraRX. For a provider with a similarly low, and genuinely transparent, consultation fee, see ZYP Medical. See our best tirzepatide providers ranking for the full field.